Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses.

EMBO J · 2019 · PMC6792016 · PMID 31483066

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Gene set enrichment analysis (GSEA) showed a highly significant enrichment of a p53 target gene signature (MSigDB P53_ downstream _ pathway ) in p53 +/+ cells compared to either p53 EE/EE or p53 −/− MEFs, but no enrichment in p53 EE/EE versus p53 −/− MEFs (Fig 1 D).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.